Pressure mounts on HSE funding decision for Friedreich’s Ataxia drug

Pressure mounts on HSE funding decision for Friedreich’s Ataxia drug

Breaking News logoBreaking News

Patients and families say Ireland is falling behind other countries where the treatment is already available.